Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.

导出 OA

翻译打印收藏纠错

作者： S K,Mahil ^[1] ; Z Z N,Yiu ^[2] ; K J,Mason ^[2] ; N,Dand ^[3] ; B,Coker ^[4] ; D,Wall ^[5] ; G,Fletcher ^[6] ; A,Bosma ^[6] ; F,Capon ^[7] ; L,Iversen ^[3] ; S M,Langan ^[8] ; P,Di Meglio ^[1] ; A H,Musters ^[9] ; D,Prieto-Merino ^[3] ; T,Tsakok ^[7] ; R B,Warren ^[9] ; C,Flohr ^[1] ; P I,Spuls ^[2] ; C E M,Griffiths ^[1] ; J,Barker ^[7] ; A D,Irvine ^[2] ; C H,Smith ^[1] ; Secure-AD and PsoProtect study groups ^[10]

作者单位： St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. ^[1] Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. ^[2] St John's Institute of Dermatology within the, School of Basic & Medical Biosciences, King's College London, London, UK. ^[3] NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, London, UK. ^[4] Hair Restoration Blackrock, Dublin, Ireland. ^[5] National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, Dublin, Ireland. ^[6] Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. ^[7] Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark. ^[8] Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK. ^[9] Clinical Medicine, Trinity College Dublin, Dublin, Ireland. ^[10]